At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 22, 2026 at 18:27 ET
Two Dyne Therapeutics directors sold a total of ~$1.15M in stock over a 7-day window, with Director Rhodes Jason P executing the bulk of the sales (~$2.6M across multiple trades). The selling represents ~0.04% of the company's $2.9B market cap, which is trivial and routine. No insider buying was reported, and the cluster is dominated by a single director's open-market sales.
- Total insider sales of ~$1.15M over 7 days, representing ~0.04% of $2.9B market cap
- Director Rhodes Jason P sold 142,924 shares for ~$2.6M across three trades (Apr 24-28)
- Director Kersten Dirk sold 2,700 shares for $53K on Apr 22
- Director Lubner David Charles gifted 53,625 shares (non-cash, $0 value) on Apr 24
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access